Press Release Details

Jun 05, 2017

QuintilesIMS to Participate in William Blair Growth Stock Conference on June 14, 2017

DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- Quintiles IMS Holdings, Inc. (NYSE:Q), a leading global provider of information, technology services and contract research to the healthcare and life sciences industries, announced today that Mike McDonnell, executive vice president and chief financial officer, will speak at the William Blair 37th Annual Growth Stock Conference in Chicago on Wednesday, June 14, 2017 at 1:20 p.m. CDT / 2:20 p.m. EDT.

A live audio webcast of the presentation will be available on the QuintilesIMS Investor Relations website at http://ir.quintilesims.com. A replay of the webcast also will be available later that day.

About QuintilesIMS

QuintilesIMS (NYSE:Q) is a leading integrated information and technology-enabled healthcare service provider worldwide, dedicated to helping its clients improve their clinical, scientific and commercial results. Formed through the merger of Quintiles Transnational and IMS Health, QuintilesIMS’s approximately 50,000 employees conduct operations in more than 100 countries. Companies seeking to improve real-world patient outcomes through treatment innovations, care provision and access can leverage QuintilesIMS’s broad range of healthcare information, technology and service solutions to drive new insights and approaches. QuintilesIMS provides solutions that span clinical to commercial, bringing customers a unique opportunity to realize the full potential of innovations and advanced healthcare outcomes.

As a global leader in protecting individual patient privacy, QuintilesIMS uses healthcare data to deliver critical, real-world disease and treatment insights. Through a wide variety of privacy-enhancing technologies and safeguards, QuintilesIMS protects individual privacy while managing information to drive healthcare forward. These insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders in the development and approval of new therapies, and to identify unmet treatment needs and understand the safety, effectiveness and value of pharmaceutical products in improving overall health outcomes. To learn more, visit www.QuintilesIMS.com.

Click here to subscribe to Mobile Alerts for QuintilesIMS.

QUINTILESIMSFIN

Source: Quintiles IMS Holdings, Inc.

QuintilesIMS Investor Relations

Andrew Markwick, 1-973-257-7144

andrew.markwick@quintilesims.com

or

QuintilesIMS Media Relations

Tor Constantino, 1-484-567-6732

tor.constantino@quintilesims.com

Investor Contact

83 Wooster Heights Road

Danbury, Connecticut 06810

USA

Tel: +1 203 448-4600